Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of Southern Denmark
About this trial
Investigation of which patients treated with paclitaxel have an increased risk of developing peripheral neuropathy.
Eligibility criteria
Qualifiers
Age > 18 years
Willing to give informed consent
Scheduled to receive neo-adjuvant or adjuvant paclitaxel treatment
Able to speak and understand Danish
Disqualifiers
Neurodegenerative diseases (e.g., neuropathy from another cause, previous apoplexy, disc herniation
Type 1 or 2 diabetes
Pregnant
Breastfeeding
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
188 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Southern Denmark
Lead sponsor
Odense University Hospital
Collaborator
Sygehus Lillebaelt
Collaborator
Sonderborg Hospital
Collaborator
Source ClinicalTrials.gov